Gene	Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Custom Driver	Custom Driver Tiers	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Tumor Site: Adrenal Glands (NLP)	Tumor Site: Bone (NLP)	Clinical Group	Clinical Summary	Tumor Site: CNS/Brain (NLP)	Current Age	Diagnosis Description	Ethnicity	Fraction Genome Altered	Sex	Gene Panel	"Gleason Score, 1st Reported (NLP)"	"Gleason Score, Highest Reported (NLP)"	Gleason Score Reported on Sample (NLP)	HER2	History for Positive PD-L1 (NLP)	HR	ICD-O Histology Description	Tumor Site: Intra Abdominal	Tumor Site: Liver (NLP)	Tumor Site: Lung (NLP)	Tumor Site: Lymph Node (NLP)	Metastatic Site	MSI Comment	MSI Score	MSI Type	Number of Tumor Registry Entries	Oncotree Code	Overall Survival (Months)	Overall Survival Status	Tumor Site: Other (NLP)	Pathological Group	Sample PD-L1 Positive (NLP)	Tumor Site: Pleura (NLP)	Primary Tumor Site	Prior Treatment to MSK (NLP)	Race	Tumor Site: Reproductive Organs (NLP)	Sample Class	Number of Samples Per Patient	Sample coverage	Sample Type	Smoking History (NLP)	Somatic Status	Stage (Highest Recorded)	TMB (nonsynonymous)	Tumor Purity
EGFR	"MSK-CHORD (MSK, Nature 2024)"	P-0076655-T01-IM7	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L858R	"OncoKB: Oncogenic, level_1, resistance NA;reVUE: no;CIViC: diagnosticCount: 0, predictiveCount: 40, prognosticCount: 1, predisposingCount: 0, oncogenicCount: 0, functionalCount: 0;MyCancerGenome: present;CancerHotspot: yes;3DHotspot: yes"			"MutationAssessor: impact: high, score: 6.998045299599963;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999;AlphaMissense: pathogenicity: pathogenic, score: 0.9968"	Missense_Mutation	SNP	Diploid	2247	SOMATIC	Unknown	MSKCC	7	55259515	55259515	T	G	7:g.55259515T>G	ENST00000275493.2:c.2573T>G	0.11		67	561		306	5	21/28		drug_response			No	Yes	4	Distant	No	89	Lung and Bronchus	Non-Spanish; Non-Hispanic	0.0094	Female	IMPACT505					Yes		"Adenocarcinoma, Nos"	No	No	Yes	Yes	Pleural Fluid	MICROSATELLITE STABLE (MSS). See MSI note below.	0.02	Stable	2	LUAD	14.30135419	0:LIVING	Yes		Yes	No	Lung	Prior medications to MSK	White	No	Tumor	1	565	Metastasis	Former/Current Smoker	Matched	Stage 4	4.101736183	30
EGFR	"MSK-CHORD (MSK, Nature 2024)"	P-0076655-T01-IM7	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	T790M	"OncoKB: Oncogenic, level_1, level_r1;reVUE: no;CIViC: diagnosticCount: 0, predictiveCount: 38, prognosticCount: 3, predisposingCount: 0, oncogenicCount: 0, functionalCount: 0;MyCancerGenome: present;CancerHotspot: yes;3DHotspot: no"			"MutationAssessor: impact: high, score: 7.1161595427664315;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1;AlphaMissense: pathogenicity: pathogenic, score: 0.966"	Missense_Mutation	SNP	Diploid	355	SOMATIC	Unknown	MSKCC	7	55249071	55249071	C	T	7:g.55249071C>T	ENST00000275493.2:c.2369C>T	0.03		20	685		348	5	20/28		drug_response		0.000058	No	Yes	4	Distant	No	89	Lung and Bronchus	Non-Spanish; Non-Hispanic	0.0094	Female	IMPACT505					Yes		"Adenocarcinoma, Nos"	No	No	Yes	Yes	Pleural Fluid	MICROSATELLITE STABLE (MSS). See MSI note below.	0.02	Stable	2	LUAD	14.30135419	0:LIVING	Yes		Yes	No	Lung	Prior medications to MSK	White	No	Tumor	1	565	Metastasis	Former/Current Smoker	Matched	Stage 4	4.101736183	30
